Key result
AI-QCT-derived total plaque volume conferred a significantly higher relative risk of MACE in women (17.7% increase per 50-mm3) compared to men (5.3% increase).
Why the study?
Coronary plaque features are imaging biomarkers of cardiovascular risk, but sex-specific patterns in their prognostic value remain less understood.
Do AI-QCT coronary plaque features associate with a higher relative risk of MACE in women compared to men with suspected coronary artery disease?
Cohort (n=3,551)
Yes
Do AI-QCT coronary plaque features associate with a higher relative risk of MACE in women compared to men with suspected coronary artery disease?
Hazard Ratio: 1.18 (95% CI 1.12–1.24)
p-value: p=<0.001
AI-QCT-derived coronary plaque features confer a significantly higher relative risk of MACE in women compared to men, suggesting a need for more aggressive preventive interventions in women with plaque.
May indicate greater plaque vulnerability in women; hypothesis-generating for sex-specific risk models, needs prospective validation.
BACKGROUND: Coronary plaque features are imaging biomarkers of cardiovascular risk, but less is known about sex-specific patterns in their prognostic value. This study aimed to define sex differences in the coronary atherosclerotic phenotypes assessed by artificial intelligence–based quantitative computed tomography (AI-QCT) and the associated risk of major adverse cardiovascular events (MACEs). METHODS: Global multicenter registry including symptomatic patients with suspicion of coronary artery disease referred for coronary computed tomography angiography. AI-QCT analyzed 16 coronary artery disease features. The primary end point was MACE defined as death, myocardial infarction, late revascularization, cerebrovascular events, unstable angina, and congestive heart failure. RESULTS: Among 3551 patients (mean age, 59±12 years; 49.5% women), MACE occurred in 3.2% of women and 6.1% of men during an average follow-up of 4.8±2.2 years. The AI-QCT features total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume were significantly higher in men ( P <0.001), and high-risk plaques were more prevalent (9.2% versus 2.5%; P <0.0001). Independent of age and cardiovascular risk factors, the AI-QCT-derived features of total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume conferred a higher relative risk of MACE in women than men. For every 50-mm 3 increase in total plaque volume, relative risk increased by 17.7% (95% CI, 1.12–1.24) in women versus 5.3% (95% CI, 1.03–1.07) in men ( P interaction <0.001); for noncalcified plaque, relative risk increased by 27.1% (95% CI, 1.17–1.38) versus 11.6% (95% CI, 1.08–1.15; P interaction =0.0015); and for calcified plaque, relative risk increased by 22.9% (95% CI, 1.14–1.33) versus 5.4% (95% CI, 1.01–1.10; P interaction =0.0012), respectively. Similarly, for percentage atheroma volume, the risk was higher in women. The findings remained unchanged when restricted to a secondary composite end point (death and myocardial infarction). CONCLUSIONS: The AI-QCT plaque features, total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume, conferred a higher relative MACE risk in women and may prompt more aggressive antiatherosclerotic therapy and reinforced preventive interventions. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04279496.
No takes yet. Share an insight, caveat, or question.
Feuchtner et al. (2025) conducted a cohort in Suspected coronary artery disease (n=3,551). Total plaque volume (per 50-mm3 increase) vs. Men (for interaction comparison) was evaluated on Major adverse cardiovascular events (MACE) (HR 1.18, 95% CI 1.12-1.24, p=<0.001). AI-QCT-derived total plaque volume conferred a significantly higher relative risk of MACE in women (17.7% increase per 50-mm3) compared to men (5.3% increase).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: